Desferroxamine an iron chelator, has been shown to be ineffective in increasing the frequency of micronuclei in bone marrow cells of mice on acute and sub-acute treatment. However, a significant mitodepressive effect is produced at the higher dose on sub-acute treatment. The mito-depressive potentials of DFO may be either due to the disproportionate ratio of Fe2 + /Fe3 + which is known to stimulate lipid peroxidation or due to total chelation of iron resulting in bone marrow depression and anemic condition.